Código QR (código de barras bidimensional)

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study

Shannon Puhalla,1 Sharon Wilks,2 Adam M Brufsky,1 Joyce O’Shaughnessy,3 Lee S Schwartzberg,4 Erhan Berrak,5 James Song,5 Linda Vahdat6 1Department of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Department of Hematology Oncology, US Oncology-Cancer Care Ce...

ver descrição completa

Na minha lista:
Principais autores: Puhalla S, Wilks S, Brufsky AM, O'Shaughnessy J, Schwartzberg LS, Berrak E, Song J, Vahdat L
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016-12-01
coleção:Breast Cancer: Targets and Therapy
Assuntos:
oncology
breast neoplasms
advanced breast cancer
chemotherapy
eribulin mesylate
trastuzumab
Acesso em linha:https://www.dovepress.com/clinical-effects-of-prior-trastuzumab-on-combination-eribulin-mesylate-peer-reviewed-article-BCTT
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados